EUVIMEDEUVIMED entdecken
Klinische StudieMultizentrische Studie

Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study

S L Fielding, M A Flower, D Ackery, J T Kemshead, L S Lashford, I Lewis

European Journal of Nuclear Medicine · 1991-05 · 18 (5) · 308-316

DOI: 10.1007/bf02285457 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift European Journal of Nuclear Medicine, 1991-05. Verfasst von S L Fielding und 5 weiteren Autor:innen. Beteiligte Einrichtung: Physics Department, Royal Marsden Hospital, Sutton, Surrey, UK. Hauptthemen laut MEDLINE: Radiometry. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In 1987, the United Kingdom Children's Cancer Study Group (UKCCSG) set up a multi-centre study to investigate the toxicity of iodine 131 metaiodobenzylguanidine (mIBG) in the treatment of resistant neuroblastoma. Since December 1987, 25 children suffering from neuroblastoma have been treated with 131I-mIBG at six UK centres. All centres followed standardised physics and clinical protocols to provide consistent toxicity and dosimetry data. These protocols describe the methods employed for both the tracer study using 131I-mIBG and the subsequent therapy. Whole-body dosimetry calculations were performed on data from the tracer study. The activity administered for therapy was the amount predicted to deliver a predefined whole-body dose. Estimates of doses delivered to various organs during treatment are given in Table 1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiometry3-IodobenzylguanidineChildChild, PreschoolHumansInfantIodine RadioisotopesIodobenzenesNeuroblastomaRadiotherapy DosageTissue Distribution

Substanzen

Iodine RadioisotopesIodobenzenes3-Iodobenzylguanidine

Autor:innen und Institutionen

  • Physics Department, Royal Marsden Hospital, Sutton, Surrey, UK.

Zitieren

APA

Fielding, S. L., Flower, M. A., Ackery, D., Kemshead, J. T., Lashford, L. S., & Lewis, I. (1991). Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study. European Journal of Nuclear Medicine, 18(5), 308-316. https://doi.org/10.1007/bf02285457

Vancouver

Fielding SL, Flower MA, Ackery D, Kemshead JT, Lashford LS, Lewis I. Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study. European Journal of Nuclear Medicine. 1991;18(5):308-316. doi:10.1007/bf02285457

BibTeX
@article{Fielding1991,
  author = {Fielding, S L and Flower, M A and Ackery, D and Kemshead, J T and Lashford, L S and Lewis, I},
  title = {Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study},
  journal = {European Journal of Nuclear Medicine},
  year = {1991},
  volume = {18},
  number = {5},
  pages = {308--316},
  doi = {10.1007/bf02285457}
}
Kostenlos starten →